ACON
NASDAQ
$3.49
Aclarion Inc (ACON)
Aclarion Inc (ACON) is a pioneering healthcare technology company that specializes in non-invasive diagnostics, focusing on musculoskeletal conditions through innovative imaging and advanced data analytics. By harnessing machine learning, Aclarion provides healthcare professionals with actionable insights that enhance clinical outcomes while optimizing costs within treatment pathways. Positioned at the vanguard of the digital health transformation, Aclarion is poised to meet the increasing demand for effective diagnostic solutions, significantly enhancing the standard of patient care in an evolving healthcare landscape. Its commitment to improving patient management establishes Aclarion as a key player in the future of healthcare delivery.
Sector:
Healthcare
Industry:
Health Information Services
Buy
Target: $7.50 (+114.90%)
Market Cap
$7.63M
P/B Ratio
0.40
Free Cash Flow Yield
-95.92%
Price Chart
Valuation
Market Cap$7.63M
P/S104.02
P/B0.40
Profitability
Total Revenue (TTM)$78K
Gross Profit (TTM)$15K
EBITDA-$8.31M
Operating Margin-14129%
EPS-$9.06
Financial Health
Free Cash Flow Yield-95.92%
Growth & Risk
Sharpe Ratio-0.23